Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Inflammatory Bowel Diseases

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MIB.0000000000000966PMID 27861181PMCID PMC5303573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LACC1 polymorphisms in inflammatory bowel disease and juvenile idiopathic arthritis

  2016cited by this paper
• Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

  2015influential reference
• Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.

  2014cited by this paper
• Gastrointestinal Histopathology in Chronic Granulomatous Disease: A Study of 87 Patients

  2013cited by this paper
• Relationship Between Proximal Crohn's Disease Location and Disease Behavior and Surgery: A Cross-Sectional Study of the IBD Genetics Consortium

  2013cited by this paper
• Using Genetic Prediction from Known Complex Disease Loci to Guide the Design of Next-Generation Sequencing Experiments

  2013cited by this paper
• Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

  2012cited by this paper
• Recent insights into the genetics of inflammatory bowel disease.

  2011cited by this paper
• Inflammatory bowel disease.

  2011cited by this paper
• Inhibition of cytokine-induced β cell apoptosis via laccase and its therapeutic advantages for insulin-dependent diabetes mellitus, type 1 diabetes.

  2010cited by this paper
• Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis.

  2010cited by this paper
• Chronic granulomatous disease

  2010cited by this paper
• A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.

  2009cited by this paper
• Inflammatory Bowel Disease in CGD Reproduces the Clinicopathological Features of Crohn's Disease

  2009cited by this paper
• Special Article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient‐based registry

  2008cited by this paper
• PLINK: a tool set for whole-genome association and population-based linkage analyses.

  2007cited by this paper
• Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)

  2007cited by this paper
• Health-Related Quality of Life of Children With Primary Immunodeficiency Disease: A Comparison Study

  2005cited by this paper
• Successful Low Toxicity Hematopoietic Stem Cell Transplantation for High-Risk Adult Chronic Granulomatous Disease Patients

  2005cited by this paper
• Long-term interferon-gamma therapy for patients with chronic granulomatous disease.

  2004cited by this paper
• Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.

  2004cited by this paper
• Long-Term Interferon-γ Therapy for Patients with Chronic Granulomatous Disease

  2004cited by this paper
• Gastrointestinal involvement in chronic granulomatous disease.

  2004cited by this paper
• Itraconazole to prevent fungal infections in chronic granulomatous disease.

  2003cited by this paper
• Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.

  2003cited by this paper
• Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England

  2003cited by this paper
• Inflammatory bowel disease.

  2002cited by this paper
• Chronic Granulomatous Disease: Report on a National Registry of 368 Patients

  2000cited by this paper
• Genetic, biochemical, and clinical features of chronic granulomatous disease.

  2000cited by this paper
• Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

  1998cited by this paper

• Additive effects of common and rare genetic variants on inflammatory bowel disease risk in a cohort with immunodeficiency.

  2026cites this paper
• The Relevance of Experimental Models in Assessing the Impact of Oxidative Stress on Intestinal Pathology

  2025cites this paper
• Multi-omics integration and machine learning identify and validate neutrophil extracellular trap-associated gene signatures in chronic rhinosinusitis with nasal polyps.

  2025cites this paper
• Non-Infectious Complications of Chronic Granulomatous Disease: Knowledge Gaps & Novel Treatment Considerations.

  2025cites this paper
• Towards IBD Prediction and Prevention: The Contribution of Genetics and Genomics.

  2025cites this paper
• Identification of common genetic factors and immune-related pathways associating more than two autoimmune disorders: implications on risk, diagnosis, and treatment

  2024cites this paper
• LACC1 deficiency leading to juvenile arthritis and anemia.

  2024cites this paper
• Inflammatory Complications in Chronic Granulomatous Disease

  2024cites this paper
• Functional neutrophil disorders: Chronic granulomatous disease and beyond

  2024cites this paper
• Adhesive thermosensitive polydopamine hydrogel containing Mn3O4 anchored halloysite clay for treatment of ulcerative colitis.

  2024cites this paper
• Host–pathobiont interactions in Crohn’s disease

  2024cites this paper
• Key Disease-Related Genes and Immune Cell Infiltration Landscape in Inflammatory Bowel Disease: A Bioinformatics Investigation

  2024cites this paper
• Dysregulated NOX1-NOS2 activity as hallmark of ileitis in mice.

  2024cites this paper
• Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards

  2023cites this paper
• Chitosan functionalized Mn3O4 nanoparticles counteracts ulcerative colitis in mice through modulation of cellular redox state

  2023cites this paper
• Whole-genome risk prediction of common diseases in human preimplantation embryos

  2022cites this paper
• NOX1 is essential for TNFα-induced intestinal epithelial ROS secretion and inhibits M cell signatures

  2022cites this paper
• LACC1 bridges NOS2 and polyamine metabolism in inflammatory macrophages

  2022cites this paper
• Chronic granulomatous disease with inflammatory bowel disease: Clinical presentation, treatment, and outcomes from the USIDNET Registry.

  2022cites this paper
• Preventing Colitis-Associated Colon Cancer With Antioxidants: A Systematic Review

  2021cites this paper
• Advanced Understanding of Monogenic Inflammatory Bowel Disease

  2021cites this paper
• LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages

  2021cites this paper
• Disease Presentation, Treatment Options, and Outcomes for Myeloid Immunodeficiencies

  2021cites this paper
• Mucosal Microbiome Profiles Polygenic Irritable Bowel Syndrome in Mestizo Individuals

  2020cites this paper
• Oxidants in Physiological Processes.

  2020cites this paper
• Role of the microbiota in ileitis of a mouse model of inflammatory bowel disease—Glutathione peroxide isoenzymes 1 and 2‐double knockout mice on a C57BL background

  2020cites this paper
• On behalf of the Paediatric IBD Porto group of ESPGHAN

  2020cites this paper
• Clinical Genomics for the Diagnosis of Monogenic forms of Inflammatory Bowel Disease: A Position Paper from The Paediatric IBD Porto Group of ESPGHAN.

  2020cites this paper
• ROS signaling in complex systems: The gut

  2020cites this paper
• Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease

  2020cites this paper
• Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

  2020cites this paper
• Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated with Monogenic Variants, Identified by Whole-exome Sequencing in 1000 Children at a Single Center.

  2020cites this paper
• Colitis susceptibility in mice with reactive oxygen species deficiency is mediated by mucus barrier and immune defense defects

  2019cites this paper
• Clinical and Molecular Features of Chronic Granulomatous Disease in Mainland China and a XL-CGD Female Infant Patient After Prenatal Diagnosis

  2019cites this paper
• NAPDH Oxidases in Inflammatory Bowel Disease.

  2019cites this paper
• Targeted Delivery of Curcumin Rescues Endoplasmic Reticulum–Retained Mutant NOX2 Protein and Avoids Leukocyte Apoptosis

  2019cites this paper
• Early Onset Granulomatous Colitis Associated with a Mutation in NCF4 Resolved with Hematopoietic Stem Cell Transplantation.

  2019cites this paper
• TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity

  2019cites this paper
• Inflammatory consequences of inherited disorders affecting neutrophil function.

  2019cites this paper
• Recent Advance in Very Early Onset Inflammatory Bowel Disease

  2019cites this paper
• New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma

  2018cites this paper
• A Spectrum of Genetic Variants Contributes to Immune Defects and Pathogenesis of Inflammatory Bowel Diseases.

  2018cites this paper
• Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease.

  2018cites this paper
• Digestion and Absorption

  2018cites this paper
• Control and dysregulation of redox signalling in the gastrointestinal tract

  2018cites this paper
• Recent advance in very early-onset inflammatory bowel disease

  2018cites this paper
• Inherited p40phox deficiency differs from classic chronic granulomatous disease

  2018cites this paper
• Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience

  2017cites this paper
• Clinical Genomics in Inflammatory Bowel Disease.

  2017cites this paper
• Clinical Genomics in In fl ammatory Bowel Disease

  2017cites this paper
• Recent advances in understanding and treating chronic granulomatous disease

  2017cites this paper
• Chronisch-entzündliche Darmerkrankung und Immundefekte

  2017cites this paper